Orbital Ameloblastic Carcinoma – Unusual Presentation in A Non-Odontogenic Location Volume 7 - Issue 2

Avinash Arjun Rao Kesari ,Shivakumar Swamy Shivalingappa , Nadezhda Niyarah Alemao*, Lohith G , Indiresh Desai and Veena Ramaswamy

• Department of Radiodiagnosis, HCG Cancer Hospital, India

Received:August 05, 2021;   Published:August 16, 2021

Corresponding author: Nadezhda Niyarah Alemao, Department of Radiodiagnosis, HCG Cancer Hospital, Bangalore, India

DOI: 10.32474/SJO.2021.07.000260

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Ameloblastic carcinoma has been described as an ameloblastoma in which there is histological evidence of carcinoma in a primary or recurrent ameloblastoma. The frequency of the lesion is estimated to be less than 1% of all ameloblastomas occurring in the mandible and maxilla.1 We present a case of a 30-year-old woman who presented with painless swelling of left upper face and recurrent upper respiratory tract infections. She was evaluated with CECT, MRI and PET-CT which showed 3.6 x 3.5 x 3.3 cm mass arising from the inferomedial wall of left orbit with sunburst periosteal reaction and cloudy osteoid matrix which was thought to be an osteosarcoma. She underwent a transorbital and trans nasal endoscopic wide local excision of the lesion which was then diagnosed as ameloblastic carcinoma on histopathology. Imaging features and pathological findings of the tumor along with novel treatment strategies and differential diagnosis are discussed in this case report.

Keywords: MRI; orbital tumor; ameloblastic carcinoma; osteosarcoma; CECT; PET

Abbreviations: 18F-FDG-PET: 18F-fluorodeoxyglucose–Positron Emission Tomography; CECT: Contrast Enhanced Computed Tomography; FLAIR: Fluid Attenuated Inversion Recovery; MRI: Magnetic Resonance Imaging; WHO: World Health Organization

Abstract| Introduction| Case Description| Discussion| Conclusion| Financial Support and Sponsorship| Conflicts of Interest| References|